Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.

Starr TN, Greaney AJ, Dingens AS, Bloom JD. · 2021

Read Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016. by Starr TN, Greaney AJ, Dingens AS, Bloom JD. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8020059.txt.

Description

Starr and co-authors map every spike mutation that lets SARS-CoV-2 escape a leading antibody drug. The antibody LY-CoV555, also called bamlanivimab, targets the spike receptor-binding domain. It was used alone and in a cocktail with LY-CoV016. Viral evolution could, in time, defeat both. The team tested all single amino acid changes in the domain.

The authors report a complete escape map for each antibody and for the pair. E484K escapes LY-CoV555, while K417N/T escapes LY-CoV016. Both changes already circulate in the South African and Brazilian lineages. The L452R change in a Californian lineage also escapes LY-CoV555. A few single changes even beat the combined cocktail. The authors urge antibody designs that spread across more epitopes.

Catalog record

CREATORStarr TN, Greaney AJ, Dingens AS, Bloom JD.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8020059

Browse the full library · About the Tower of Babel